MPS Limited (BOM:532440)
India · Delayed Price · Currency is INR 2,307.10
-50.30 (-2.13%)
At close: Aug 1, 2025
Intra-Cellular Therapies Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Net Income | - | 1,489 | 1,188 | 1,092 | 871.21 | 585.6 | Upgrade |
Depreciation & Amortization | - | 274.1 | 168.72 | 168.2 | 169.32 | 165.2 | Upgrade |
Other Amortization | - | - | 31.11 | 26.71 | 39.45 | 46.96 | Upgrade |
Loss (Gain) From Sale of Assets | - | -1.3 | -0.61 | -0.81 | -0.99 | 1.24 | Upgrade |
Loss (Gain) From Sale of Investments | - | -49.3 | -18.22 | -4.47 | -3.36 | -13.55 | Upgrade |
Stock-Based Compensation | - | 8.5 | 4.62 | - | - | - | Upgrade |
Provision & Write-off of Bad Debts | - | 1 | 23.22 | -14.07 | 22.94 | 19.81 | Upgrade |
Other Operating Activities | - | -69.2 | -46.52 | 24.73 | -95.99 | 114.54 | Upgrade |
Change in Accounts Receivable | - | -147.4 | 58.97 | 25.57 | 46.12 | -94.01 | Upgrade |
Change in Accounts Payable | - | 4.3 | -59.16 | 5.6 | -39.24 | -27.7 | Upgrade |
Change in Other Net Operating Assets | - | -500.9 | -169.44 | -195.18 | 139.32 | 195.62 | Upgrade |
Operating Cash Flow | - | 1,009 | 1,180 | 1,128 | 1,149 | 993.72 | Upgrade |
Operating Cash Flow Growth | - | -14.53% | 4.63% | -1.79% | 15.60% | 88.43% | Upgrade |
Capital Expenditures | - | -62.2 | -36.98 | -42.88 | -41.75 | -58.72 | Upgrade |
Sale of Property, Plant & Equipment | - | 2.1 | 0.62 | 1.66 | 2.25 | 0.85 | Upgrade |
Cash Acquisitions | - | - | -749.44 | -332.72 | - | -444.87 | Upgrade |
Sale (Purchase) of Intangibles | - | -24 | -31.44 | -0.97 | -2.23 | -8.72 | Upgrade |
Investment in Securities | - | 13.4 | 998.21 | -310.88 | 125.54 | -135.15 | Upgrade |
Other Investing Activities | - | 13 | 70.4 | 38.38 | 69.78 | 53.71 | Upgrade |
Investing Cash Flow | - | -57.7 | 251.37 | -647.41 | 153.59 | -592.9 | Upgrade |
Long-Term Debt Repaid | - | -42.9 | -39.58 | -49.11 | -97.02 | -106.52 | Upgrade |
Net Debt Issued (Repaid) | - | -42.9 | -39.58 | -49.11 | -97.02 | -106.52 | Upgrade |
Repurchase of Common Stock | - | -3.3 | -30.28 | -128.07 | -1,048 | -340 | Upgrade |
Common Dividends Paid | - | -1,345 | -857.51 | -513.17 | - | - | Upgrade |
Other Financing Activities | - | -11.5 | -6.28 | -10.63 | -10.08 | -82.82 | Upgrade |
Financing Cash Flow | - | -1,402 | -933.65 | -700.99 | -1,155 | -529.34 | Upgrade |
Foreign Exchange Rate Adjustments | - | 5.1 | 1.86 | 5.45 | 2.17 | -22.6 | Upgrade |
Net Cash Flow | - | -446 | 499.97 | -214.75 | 149.41 | -151.12 | Upgrade |
Free Cash Flow | - | 946.7 | 1,143 | 1,085 | 1,107 | 935 | Upgrade |
Free Cash Flow Growth | - | -17.20% | 5.35% | -1.96% | 18.40% | 86.32% | Upgrade |
Free Cash Flow Margin | - | 13.02% | 20.97% | 21.66% | 24.66% | 22.13% | Upgrade |
Free Cash Flow Per Share | - | 55.77 | 67.35 | 63.49 | 61.76 | 50.97 | Upgrade |
Cash Interest Paid | - | 11.5 | 6.28 | 10.63 | 2.25 | 1.39 | Upgrade |
Cash Income Tax Paid | - | 495.4 | 414.5 | 353.89 | 344.96 | 193.29 | Upgrade |
Levered Free Cash Flow | - | 732.72 | 1,890 | 860.37 | 890.95 | 844.11 | Upgrade |
Unlevered Free Cash Flow | - | 737.6 | 1,896 | 867.3 | 900.53 | 856.84 | Upgrade |
Change in Net Working Capital | - | 605.61 | -821.34 | 148.87 | -75.95 | -169.66 | Upgrade |
Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.